REPLAY: House Hearing Examines FDA’s Role in US Drug Innovation
The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, on April 22, 2025. (Jose Luis Magana/AP Photo)
Read the full articleYou might also wanna read
Health Subcommittee Holds Hearing to Examine Ways to Drive Efficiencies Across Early-Stage Clinical Development
**WASHINGTON, D.C.** - Today, Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, led a hearing titled _Maintaining
FDA Issues Revised Draft Guidance on Demonstrating Substantial Evidence of Effectiveness for Human Drugs and Biological Products
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) unveiled Operation TrialBlazer, a department-wide effort to acceler
Statement on FDA’s delay of GRAS amendment proposal
Statement on FDA’s delay of GRAS amendment proposal Iris Myers July 9, 2026 WASHINGTON – The Food and Drug Administration’s plan to amend th
At the Half: No Free Kicks in FDA’s 2026 Enforcement
As the World Cup has captured the attention of viewers around the globe, so has the Food and Drug Administration (FDA) when it comes to taki
FDA Explores Expediting Clinical Trials: Announces Ambitious New Drug Pilot Program
On June 24, 2026, the Food and Drug Administration (FDA) published a notice of availability in the Federal Register requesting information a
STAT+: FDA finalists under review
Three top contenders to run the FDA are under review by the White House
Comments
Sign in to join the conversation.
No comments yet. Be the first.